In the present article we described the findings of the first study, to our knowledge, investigating the relations between circadian clock genes DNA genetic variations and the susceptibility to soft tissue sarcoma or the outcome of sarcoma bearing patients. The gene discussed is CLOCK; the disease is soft tissue sarcoma.